Android app Apple app link

Arcus Biosciences, Inc. (RCUS) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$21.43
Day's range
$23.49

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/07/2026 Goldman Sachs Richard Law $42.00 $28.33   48.25%
07/20/2026 H.C. Wainwright Emily Bodnar $45.00 $27.37   64.41%
01/12/2026 Goldman Sachs Richard Law $28.00 $21.30   31.46%
10/30/2025 Goldman Sachs Salveen Richter $16.00 $20.64   -22.48%
10/07/2025 Truist Financial Asthika Goonewardene $39.00 $14.48   169.34%
05/07/2025 Wells Fargo Eva Fortea Verdejo $26.00 $8.12   220.2%
10/24/2024 Citigroup Yigal Nochomovitz $46.00 $17.42   164.14%
10/21/2024 H.C. Wainwright Emily Bodnar $20.00 $18.44   8.46%
10/08/2024 Wells Fargo Eva Fortea Verdejo $29.00 $18.08   60.4%
10/08/2024 Morgan Stanley Judah Frommer $35.00 $18.08   93.58%
08/09/2024 Bank of America Securities Jason Zemansky $23.00 $13.69   68.01%
07/08/2024 Barclays Peter Lawson $25.00 $14.00   78.57%
06/24/2024 Truist Financial Asthika Goonewardene $44.00 $16.45   167.48%
06/04/2024 Barclays Peter Lawson $35.00 $16.15   116.72%
05/11/2022 Wedbush Robert Driscoll $42.00 $24.01   74.93%

Arcus Biosciences Inc FAQ's

Arcus Biosciences Inc has been rated by research analysts at Goldman Sachs, Wedbush, H.C. Wainwright, Truist Financial, Morgan Stanley, Leerink Partners in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.